Search results
An orphan drug is a pharmaceutical agent that is developed to treat certain rare medical conditions. An orphan drug would not be profitable to produce without government assistance, due to the small population of patients affected by the conditions. The conditions that orphan drugs are used to treat are referred to as orphan diseases.
Apr 14, 2022 · The Ministry of Health (MOH) Malaysia recognises the needs of the patients with rare diseases in Malaysia. Under the Malaysian National Medicines Policy (MNMP) one of the focus areas to improve on is to enhance the accessibility of life-saving products and orphan medicines without compromising.
Sep 27, 2023 · Orphan drugs are medicines for rare diseases that affect fewer than 200,000 people in the U.S. Learn about the Orphan Drug Act, which encourages drug makers to develop orphan drugs with tax benefits and exclusive rights.
and orphan medicines without compromising safety, quality and efficacy of the medicines. The purpose of this guideline is to facilitate access to medicines required for the
The FDA has authority to grant orphan drug designation to a drug or biological product to prevent, diagnose or treat a rare disease or condition. Orphan drug designation qualifies sponsors...
Feb 28, 2024 · Learn what an orphan drug is, how it is developed and why it is important for rare disease patients. See how Johnson & Johnson is committed to advancing orphan drug research and access with incentives and collaborations.
Learn about the EU's role in facilitating the development and authorisation of medicines for rare diseases, which are termed 'orphan medicines'. Find out how to apply for orphan designation, what incentives are available, and how EMA works with international partners on orphan medicines.
